ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.000,97
-0,72%
S&P 500
5.116,17
0,00%
Dow Jones
38.386,09
0,00%
Euro vs US Dollar
1,07007
-0,14%
Bitcoin
61.266,46
-4,03%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. DermTech Inc (DMTK)

  7. DermTech Inc (DMTK) News

DMTK DermTech Inc

0,595
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 14:51:53
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
DermTech Inc DMTK NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 0,595 14:51:53
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,595
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.4.202422:15BWDermTech to Explore Strategic Alternatives and Implement..
01.4.202422:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
08.3.202414:05BWDermTech Presents Research Abstracts at the 2024 American..
08.3.202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:17EDGAR2Form S-8 - Securities to be offered to employees in employee..
29.2.202422:53EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.2.202422:05EDGAR2Form 8-K - Current report
29.2.202422:01BWDermTech Reports Fourth-Quarter 2023 Financial Results
13.2.202414:05BWDermTech Announces Release Date for Fourth-quarter 2023..
31.1.202422:32EDGAR2Form 8-K - Current report
31.1.202422:30BWDermTech Announces Additional Restructuring Actions to Focus..
18.1.202414:05BWDermTech Announces Positive Topline Results From a Study..
16.1.202414:05BWDermTech Simplifies the DermTech Melanoma Test (DMT) by..
10.1.202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202414:00BWDermTech Announces Positive Topline Results From Trust 2..
14.12.202322:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
12.12.202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.12.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
28.11.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
21.11.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
14.11.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
07.11.202319:57PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
02.11.202321:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202321:09EDGAR2Form 8-K - Current report
02.11.202321:01BWDermTech Reports Third-Quarter 2023 Financial Results
31.10.202310:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
24.10.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12.10.202314:05BWDermTech Announces Release Date for Third-Quarter 2023..
23.9.202302:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.9.202302:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
21.9.202322:05BWDermTech Grants New CCO Mark Aguillard Inducement Award..
19.9.202314:05BWDermTech Announces Contracts With Highmark for the..
13.9.202302:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.9.202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.9.202302:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.9.202314:10EDGAR2Form 8-K - Current report
11.9.202314:05BWDermTech Appoints Mark Aguillard as Chief Commercial Officer
25.8.202314:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
12.8.202300:44EDGAR2Form 144 - Report of proposed sale of securities
07.8.202322:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
03.8.202322:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202322:07EDGAR2Form 8-K - Current report
03.8.202322:01BWDermTech Reports Second-Quarter 2023 Financial Results
19.7.202314:00BWDermTech Announces Favorable Coverage Policy With Blues Plan..
17.7.202314:00BWDermTech Announces Release Date for Second-Quarter 2023..
14.7.202302:17EDGAR2Form 144 - Report of proposed sale of securities
13.7.202322:09EDGAR2Form 8-K/A - Current report: [Amend]

Kürzlich von Ihnen besucht

NASDAQ
DMTK
DermTech
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten